Molecular and Cellular Biology, December 2000, p. 9434-9434, Vol. 20, No. 24
Requirement for TAFII250 Acetyltransferase
Activity in Cell Cycle Progression
Department of Pharmacology, School of Medicine, University of
Washington, Seattle, Washington 98195-7280
Volume 20, number 4, p. 1134-1139, 2000. Since publication of
this article, we found that the acetyl coenzyme A binding site TAFII250 mutant contained the ts13 mutation (G716D) as well
as the reported G992D, G994D mutations. The presence of the ts13 mutation had been unintentionally introduced during the mutagenesis process. Since the ts13 TAFII250 mutant has a defect in
histone acetyltransferase (HAT) activity (see Fig. 1) and fails to
rescue the transcriptional and proliferative defect in ts13 cells, we suspected that our results might be attributed solely to the presence of the ts13 (G716D) mutation. We therefore generated the correct acetyl
coenzyme A binding site mutations and found that the G992D and G994D
mutations alone do not compromise TAFII250 HAT activity. In
addition, the acetyl coenzyme A mutant is fully capable of rescuing
ts13 cells from cell cycle arrest and restoring transcription to the
cyclin D1 promoter at 39.5°C.
Although these findings differ from our published results, they do not
contradict or disprove our hypothesis that TAFII250 HAT
activity is necessary for the G1/S transition. We regret
our error and apologize for any confusion it may have caused.
0270-7306/00
Copyright © 2000, American Society for Microbiology. All rights reserved.
AUTHOR'S CORRECTION
Molecular and Cellular Biology, December 2000, p. 9434-9434, Vol. 20, No. 24
0270-7306/00
Copyright © 2000, American Society for Microbiology. All rights reserved.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»